Trademark/Service Mark Application, Principal Register
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)
Trademark/Service Mark Application, Principal Register
The color(s) grey and turquoise is/are claimed as a feature of the mark.
*DESCRIPTION OF THE MARK
(and Color Location, if applicable)
The mark consists of the stylized wording "SEBELA" in turquoise above the word "PHARMACEUTICALS" in grey, appearing to the right of a stylized
reverse letter "S" with a horizontal line and three dots all in grey.
PIXEL COUNT ACCEPTABLE
NO
PIXEL COUNT
966 x 403
REGISTER
Principal
APPLICANT INFORMATION
*OWNER OF MARK
Sebela Ireland Limited
INTERNAL ADDRESS
3rd Floor, West Wing, Adelaide Chambers
*MAILING ADDRESS
Peter Street
*CITY
Dublin
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
Ireland
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
8
*EMAIL ADDRESS
tm@gbpatent.com
LEGAL ENTITY INFORMATION
TYPE
company
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY UNDER WHICH ORGANIZED
Ireland
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS
005
*IDENTIFICATION
Pharmaceutical and medicated preparations, namely, for use in dermatology, gastroenterology, rheumatology, and for use in the treatment of
psychiatric disorders; Pharmaceutical and medicated preparations, namely, for use in the treatment of pain and inflammation; Pharmaceutical preparations and substances directed to women's health for
use in the treatment, alleviation and prevention of thermoregulatory dysfunctions and vasomotor symptoms including hot flashes, hot flushes, night awakenings, night sweats, and such disorders and
conditions associated with perimenopause, menopause and hormonal deficiencies; Menstrual symptom treatment preparations; Pharmaceutical and medicated preparations for use in nephrology, neurology,
oncology, urology, andrology and cardiology, and for use in the treatment of nasal allergies, respiratory allergies, and for use as anti-infectives; contraceptive preparations; dietary and
nutritional supplements; prenatal vitamins; pharmaceutical products for the treatment of bone diseases; preparations for the suppression of hormones; pharmaceutical preparations and substances
directed to women's health for use in the treatment, alleviation and prevention of overactive bladder, female sexual dysfunction, infertility, endometriosis, vaginitis, osteoporosis/osteopenia,
pelvic pain, dyspareunia, and candidiasis; Diagnostic agents, preparations and substances for medical purposes; all of the aforesaid goods not for use as a product name of a pharmaceutical
product
At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the
submission of the foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.
ATTORNEY INFORMATION
NAME
Jeffrey H. Handelsman
ATTORNEY DOCKET NUMBER
T59044
ATTORNEY BAR MEMBERSHIP NUMBER
XXX
YEAR OF ADMISSION
XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY
XX
FIRM NAME
Greenblum & Bernstein, P.L.C.
STREET
1950 Roland Clarke Place
CITY
Reston
STATE
Virginia
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
United States
ZIP/POSTAL CODE
20191-1411
PHONE
703-716-1191
FAX
703-716-1180
EMAIL ADDRESS
eteas@gbpatent.com
OTHER APPOINTED ATTORNEY
Neil F. Greenblum; Bruce H. Bernstein; William S. Boshnick; Jill M. Browning
DOMESTIC REPRESENTATIVE INFORMATION
NAME
Jeffrey H. Handelsman
FIRM NAME
Greenblum & Bernstein, P.L.C.
STREET
1950 Roland Clarke Place
CITY
Reston
STATE
Virginia
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
United States
ZIP CODE
20191-1411
PHONE
703-716-1191
FAX
703-716-1180
EMAIL ADDRESS
eteas@gbpatent.com
CORRESPONDENCE INFORMATION
NAME
Jeffrey H. Handelsman
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE
eteas@gbpatent.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES)
NOT PROVIDED
FEE INFORMATION
APPLICATION FILING OPTION
TEAS Standard
NUMBER OF CLASSES
1
APPLICATION FOR REGISTRATION PER CLASS
275
*TOTAL FEES DUE
275
*TOTAL FEES PAID
275
SIGNATURE INFORMATION
SIGNATURE
/Jeffrey H. Handelsman/
SIGNATORY'S NAME
Handelsman, Jeffrey H.
SIGNATORY'S POSITION
Attorney for Applicant, MD Bar (Ref.: T59044)
SIGNATORY'S PHONE NUMBER
703-716-1191
DATE SIGNED
03/03/2020
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)
Trademark/Service Mark Application, Principal Register
Serial Number:88819213
Filing Date:03/03/020
To the Commissioner for Trademarks:
MARK: SEBELA PHARMACEUTICALS (stylized and/or with design, see mark)
The literal element of the mark consists of SEBELA PHARMACEUTICALS. The color(s) grey and turquoise is/are claimed as a feature of the mark. The mark consists of the stylized wording "SEBELA" in
turquoise above the word "PHARMACEUTICALS" in grey, appearing to the right of a stylized reverse letter "S" with a horizontal line and three dots all in grey.
The applicant, Sebela Ireland Limited, a company organized under the laws of Ireland, having an address of
3rd Floor, West Wing, Adelaide Chambers
Peter Street
Dublin 8
Ireland
tm@gbpatent.com
requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C.
Section 1051 et seq.), as amended, for the following:
International Class 005: Pharmaceutical and medicated preparations, namely, for use in dermatology, gastroenterology, rheumatology, and for use in the treatment of psychiatric disorders;
Pharmaceutical and medicated preparations, namely, for use in the treatment of pain and inflammation; Pharmaceutical preparations and substances directed to women's health for use in the treatment,
alleviation and prevention of thermoregulatory dysfunctions and vasomotor symptoms including hot flashes, hot flushes, night awakenings, night sweats, and such disorders and conditions associated
with perimenopause, menopause and hormonal deficiencies; Menstrual symptom treatment preparations; Pharmaceutical and medicated preparations for use in nephrology, neurology, oncology, urology,
andrology and cardiology, and for use in the treatment of nasal allergies, respiratory allergies, and for use as anti-infectives; contraceptive preparations; dietary and nutritional supplements;
prenatal vitamins; pharmaceutical products for the treatment of bone diseases; preparations for the suppression of hormones; pharmaceutical preparations and substances directed to women's health for
use in the treatment, alleviation and prevention of overactive bladder, female sexual dysfunction, infertility, endometriosis, vaginitis, osteoporosis/osteopenia, pelvic pain, dyspareunia, and
candidiasis; Diagnostic agents, preparations and substances for medical purposes; all of the aforesaid goods not for use as a product name of a pharmaceutical product
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
Priority based on foreign filing: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services and asserts a claim of
priority based on Ireland application number FIIE202000000113663, filed 02/26/2020.
INTENT TO PERFECT 44(d) : At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the submission of the
foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.
The owner's/holder's proposed attorney information: Jeffrey H. Handelsman. Other appointed attorneys are Neil F. Greenblum; Bruce H. Bernstein; William S. Boshnick; Jill M. Browning. Jeffrey H.
Handelsman of Greenblum & Bernstein, P.L.C., is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
1950 Roland Clarke Place
Reston, Virginia 20191-1411
United States
703-716-1191(phone)
703-716-1180(fax)
eteas@gbpatent.com
The docket/reference number is T59044.
Jeffrey H. Handelsman submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any
U.S. Commonwealth or territory.
The applicant hereby appoints Jeffrey H. Handelsman of Greenblum & Bernstein, P.L.C.
1950 Roland Clarke Place
Reston Virginia 20191-1411
United States
703-716-1191(phone)
703-716-1180(fax)
eteas@gbpatent.com
as applicant's representative upon whom notice or process in the proceedings affecting the mark may be served.
The applicant's current Correspondence Information:
Jeffrey H. Handelsman
PRIMARY EMAIL FOR CORRESPONDENCE: eteas@gbpatent.com SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NOT PROVIDED
Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed,
and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $275 has been submitted with the application, representing payment for 1 class(es).
Declaration
Declaration Signature
Signature: /Jeffrey H. Handelsman/ Date: 03/03/2020
Signatory's Name: Handelsman, Jeffrey H.
Signatory's Position: Attorney for Applicant, MD Bar (Ref.: T59044)
Payment Sale Number: 88819213
Payment Accounting Date: 03/03/2020
Serial Number: 88819213
Internet Transmission Date: Tue Mar 03 16:18:14 ET 2020
TEAS Stamp: USPTO/BAS-XXX.XXX.XXX.XXX-20200303161814
115081-88819213-7109144bacc18604fe7c8d5a
9b216287481b3ff3667fa8795869ce28fb8e9ef7
b69-CC-18127966-20200303161353402123